Publication | Closed Access

Tamibarotene maintenance improved relapse-free survival of acute promyelocytic leukemia: a final result of prospective, randomized, JALSG-APL204 study

Hematological MalignancyOncologyMixed-phenotype Acute LeukemiaHematologyRelapse-free SurvivalTamibarotene MaintenanceJalsg-apl204 StudyPharmacotherapyMedicineRadiation OncologyCancer ResearchHealth Sciences